Navigation Links
Oncothyreon reports second quarter 2009 financial results
Date:8/12/2009

le" and similar expressions are intended to identify forward-looking statements. These forward-looking statements include our expectations regarding future expenses, clinical development activities and the use and adequacy of cash resources.

Forward-looking statements involve risks and uncertainties related to our business and the general economic environment, many beyond our control. These risks, uncertainties and other factors could cause our actual results to differ materially from those projected in forward-looking statements, including the risks associated with the costs and expenses of developing our product candidates, the adequacy of financing and cash reserves on hand, changes in general accounting policies, general economic factors, achievement of the results we anticipate from our clinical trials with our products and our ability to adequately obtain and protect our intellectual property rights. Although we believe that the forward-looking statements contained herein are reasonable, we can give no assurance that our expectations are correct. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. For a detailed description of our risks and uncertainties, you are encouraged to review the official corporate documents filed with the securities regulators in the United States on U.S. EDGAR and in Canada on SEDAR. Oncothyreon does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof.

Additional Information

Additional information relating to Oncothyreon can be found on U.S. EDGAR at www.sec.gov and on SEDAR at www.sedar.com.

                               Oncothyreon Inc.

     Consolidated Statements of Operation
'/>"/>
SOURCE  Oncothyreon Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 

Related biology technology :

1. Biomira announces plan to change name to Oncothyreon
2. Oncothyreon highlights corporate and clinical objectives for 2008
3. Oncothyreon to present at BIO CEO & Investor Conference
4. Oncothyreon launches new corporate website
5. Oncothyreons PX-478 is effective in preclinical model of human lung cancer
6. Oncothyreon announces March 10th webcast of fourth quarter and full year financial results conference call
7. Oncothyreon reports full year and fourth quarter 2007 financial results
8. Oncothyreon to present at upcoming investment conferences
9. Oncothyreon announces issuance of patent for PX-867
10. Oncothyreon announces effectiveness of shelf registration statement
11. Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... have observed the "hot electron" effect in a solar ... elusive charges using ultra-thin solar cells, opening a potential ... in the current online edition of Applied Physics ... cells, it generates free electrons in a range of ... the electrons must reach the bottom of the conduction ...
(Date:12/11/2009)... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ONCY ... appointment of Dr. Alan Warrander to the role ... Development. ,, "Dr. Warrander will be responsible for ... REOLYSIN(R)," said Dr. Brad Thompson, President and CEO ... design of a Phase 3 trial examining REOLYSIN ...
(Date:12/10/2009)... the National Institutes of Health (NIH), awarded a $2.18 million ... a non-invasive, passive diffusion-based treatment for severe, non-infectious uveitis. ... ... UT (PRWEB) December 10, 2009 -- The National Eye Institute ... awarded a $2.18 million grant to Aciont Inc. to help ...
(Date:12/10/2009)... China Biologic,Products, Inc. (Nasdaq: CBPO ) ("China ... biopharmaceutical companies in China, today announced,that the Company,s ... at the,NASDAQ MarketSite in New York City at ... China Biologic,s common stock ... 2, 2009, under the ticker symbol "CBPO." , ...
Breaking Biology Technology:Elusive 'hot' electrons captured in ultra-thin solar cells 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3China Biologic Products to Ring NASDAQ Opening Bell 2China Biologic Products to Ring NASDAQ Opening Bell 3
... March 4 Denis A. Cortese, M.D., president ... vision for personalized healthcare in,America at a time ... the healthcare system. , ... medicine for its,patients. By targeting specific treatments to ...
... Technology to CBI,s DNA Forensic Operations Presented ... Meeting -- Shows ZyGEM,s forensicGEM(TM) DNA Extraction ... Minimize Potential for Contamination and Error -SOLANA ... Va., March 4 ZyGEM Corp. Ltd. ...
... 4 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: ... and fiscal year 2008 financial results will be released ... will host a conference call and live webcast at ... company,s financial results and provide a 2009 corporate outlook. ...
Other Biology Technology:Mayo Clinic CEO Offers New Vision for Personalized Patient Care 2Mayo Clinic CEO Offers New Vision for Personalized Patient Care 3Commonwealth Biotechnologies Presents Data at Forensic Sciences Meeting Confirming Benefits of ZyGEM's DNA Extraction Technology 2Commonwealth Biotechnologies Presents Data at Forensic Sciences Meeting Confirming Benefits of ZyGEM's DNA Extraction Technology 3
(Date:12/11/2009)... increases, growers are being challenged to bring consistently ... bottom line, orchard owners are experimenting with new ... labor costs. , Hand thinning, a common practice ... is among the most labor-intensive of orchard practices, ... and, ultimately, prices paid by consumers. A research ...
(Date:12/11/2009)... identify and degrade the diverse types of defective proteins ... researchers Sabine C. Horn, Professor Thomas Sommer, Professor Udo ... Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have now ... enzyme complex that plays a critical role in the ... the identification and disposal of various defectively produced proteins. ...
(Date:12/11/2009)... New discoveries about the deep ocean,s temperature variability and ... conditions. , The deep ocean is affected more by ... for more accurate predictions of factors such as sea ... surface temperatures have also been found to result in ... results in a faster transport of large quantities of ...
Breaking Biology News(10 mins):Horizontal string trimmer reduces labor costs, increases peach size 2MDC researchers identify a scaffold regulating protein disposal 2New discoveries could improve climate projections 2Axsun Technologies A Wholly Owned Subsidiary of Volcano Corporation Announces Breakthrough Integrated Light Source Architecture for Optical Coherenc 6753 1Axsun Technologies A Wholly Owned Subsidiary of Volcano Corporation Announces Breakthrough Integrated Light Source Architecture for Optical Coherenc 6753 2Axsun Technologies A Wholly Owned Subsidiary of Volcano Corporation Announces Breakthrough Integrated Light Source Architecture for Optical Coherenc 6753 3Axsun Technologies A Wholly Owned Subsidiary of Volcano Corporation Announces Breakthrough Integrated Light Source Architecture for Optical Coherenc 6753 4Axsun Technologies A Wholly Owned Subsidiary of Volcano Corporation Announces Breakthrough Integrated Light Source Architecture for Optical Coherenc 6753 5Bayer Express Your Simple Win Creativity Contest Grand Prize Winners Announced 6750 1Bayer Express Your Simple Win Creativity Contest Grand Prize Winners Announced 6750 2Bayer Express Your Simple Win Creativity Contest Grand Prize Winners Announced 6750 3Researchers find increased dairy intake reduces risk of uterine fibroids in black women 62604 1Researchers find increased dairy intake reduces risk of uterine fibroids in black women 62604 2
... Schizophrenia is a developmental disorder with a large genetic ... treat some of the symptoms of schizophrenia, but are ... Unfortunately, it is difficult to predict the effectiveness of ... John H. Krystal, M.D., Editor of Biological Psychiatry ...
... A new scientific review of the most current research ... to be stronger than when the FDA initially approved ... , Dr. James W. Anderson, professor of medicine ... of Medicine, co-authors "The Oatmeal-Cholesterol Connection: 10 Years Later" ...
... Conn., Jan. 7 Accu-Time Systems, Inc., the,leading ... access products, today announced the launch of its ... a member of the,Global Series from ATS., ... that,renders traditional "time clocks" obsolete by removing limitations ...
Other Biology News:Genetic variant predicts antipsychotic response for schizophrenia patients by ethnicity 2Oatmeal's health claims strongly reaffirmed, science shows 2Accu-Time Systems, Inc. Announces Launch of Next Generation Human Capital Management (HCM) solutions: Global Series(TM) 2
...
BD Primaria 100 mm Cell Culture Dish, surface-modified polystyrene for enhanced cell culture. (200/ca) Packaging: 20 / sleeve, 200 / case ...
The F40 piston assembly is supplied as two assemblies to service one F40 pump of a BioLogic DuoFlow workstation....
... The pAcAB4 vector is a 10.0 kb ... contains two,copies of the AcNPV polyhedrin promoter ... the first p10,promoter is a Sma I ... sequences. Upstream of this,an inverted polyhedrin promoter ...
Biology Products: